NCAPD3 promotes osteosarcoma progression by modulating macrophage polarization and tumor cell proliferation
Open Access
- 9 May 2026
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 24 (1)
Abstract
Osteosarcoma (OS) is the most common primary malignant bone tumor in children and adolescents, characterized by aggressive behavior and poor prognosis. DesKeywords
Funding Information
- National Natural Science Foundation of China (82172500)
- National Natural Science Foundation of China (82103228)
- National Natural Science Foundation of China (82272664)
- Hunan Provincial Innovation Foundation for Postgraduate (CX20230372)
- Fundamental Research Funds for Central Universities of the Central South University (2024ZZTS0174)
This publication has 34 references indexed in Scilit:
- Tumor microenvironment in osteosarcoma: From cellular mechanism to clinical therapyGenes & Diseases, 2025
- NCAPD3 promotes diffuse large B-cell lymphoma progression through modulating SIRT1 expression in an H3K9 monomethylation-dependent mannerJournal of Advanced Research, 2024
- Tumor-associated macrophages induce inflammation and drug resistance in a mechanically tunable engineered model of osteosarcomaBiomaterials, 2023
- The role of tumor-associated macrophages in osteosarcoma progression – therapeutic implicationsCellular Oncology, 2021
- lncRNA SNHG10 Promotes the Proliferation and Invasion of Osteosarcoma via Wnt/β-Catenin SignalingMolecular Therapy Nucleic Acids, 2020
- Targeting tumor-associated macrophages for cancer immunotherapyBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2020
- DNA damage-induced inflammation and nuclear architectureMechanisms of Ageing and Development, 2017
- Progress in tumor-associated macrophage (TAM)-targeted therapeuticsAdvanced Drug Delivery Reviews, 2017
- Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic ActivityCell, 2015
- Tumor-Associated Macrophages: From Mechanisms to TherapyImmunity, 2014